Pancreatoduodenectomy clinical trials

Explore recruiting pancreatoduodenectomy clinical trials.

Recruiting pancreatoduodenectomy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pancreatoduodenectomy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Perioperative hydrocortisone treatment in pancreatoduodenectomy – randomised double-blinded placebo-controlled interventional trial (PD-HYDRA)

Germany

Phase II and Phase III (Integrated) EU CTIS Study details

TransNiDeG - The Effect of Transcutaneous Nicotine Administration on the Development of Delayed Gastric Emptying following Pancreatoduodenectomy - a randomized, placebo-controlled, double-blind, multicenter trial

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial

Netherlands, Finland, Sweden, Italy, Norway, Belgium +1 more

Therapeutic use (Phase IV) EU CTIS Study details

(SPARROW) Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple’s procedure (SPARROW): a multicenter, randomized controlled trial

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Pancreatoduodenectomy trials by city

Pancreatoduodenectomy in Toronto Pancreatoduodenectomy in Vancouver Pancreatoduodenectomy in Montreal Pancreatoduodenectomy in Calgary Pancreatoduodenectomy in Edmonton Pancreatoduodenectomy in Ottawa Pancreatoduodenectomy in Winnipeg Pancreatoduodenectomy in Quebec City Pancreatoduodenectomy in Hamilton Pancreatoduodenectomy in Kitchener Pancreatoduodenectomy in London Pancreatoduodenectomy in Halifax Pancreatoduodenectomy in New York Pancreatoduodenectomy in Los Angeles Pancreatoduodenectomy in Chicago Pancreatoduodenectomy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease